Profit Margin (Quarterly) Chart

Historical Profit Margin (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 2.44%
March 31, 2026 -0.14%
December 31, 2025 -10.38%
September 30, 2025 1.46%
June 30, 2025 -4.36%
March 31, 2025 -8.20%
December 31, 2024 18.42%
September 30, 2024 7.71%
June 30, 2024 15.48%
March 31, 2024 22.36%
December 31, 2023 -2.96%
September 30, 2023 12.02%
June 30, 2023 10.09%
March 31, 2023 -5.98%
December 31, 2022 -23.97%
September 30, 2022 11.25%
June 30, 2022 1.67%
March 31, 2022 -22.21%
December 31, 2021 -4.53%
Date Value
September 30, 2021 -22.57%
June 30, 2021 -24.03%
March 31, 2021 -3.49%
December 31, 2020 -60.53%
September 30, 2020 -23.95%
June 30, 2020 -36.39%
March 31, 2020 10.56%
December 31, 2019 9.23%
September 30, 2019 3.68%
June 30, 2019 1.35%
March 31, 2019 -2.75%
December 31, 2018 -23.12%
September 30, 2018 -1.89%
June 30, 2018 -6.89%
March 31, 2018 -15.16%
December 31, 2017 -66.60%
September 30, 2017 -21.05%
June 30, 2017 -5.54%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Getinge AB 10.01%
Xvivo Perfusion AB 6.81%
Abbott Laboratories 7.37%
AngioDynamics, Inc. -8.77%
Alphatec Holdings, Inc. -12.07%